ArticleCell death & disease2026

CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma.

Fabiana Moresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.